Search Within

Nicholas D Socci

  1. "2014"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (4)
Groups
  1. GSK Faculty (10)
  2. Department of Pathology and Laboratory Medicine (6)
  3. Epidemiology and Biostatistics (6)
  4. Human Oncology and Pathogenesis Program (6)
  5. Sloan Kettering Institute Postdocs (6)
  6. Department of Medicine (5)

More Groups

People
  1. Agnes Viale (5)
  2. Marc Ladanyi (4)
  3. Gkeok Stzuan Diana Lim (3)
  4. Li-Xuan Qin (3)
  5. Michael Berger (3)
  6. Nabahet Ameur (3)

More People

Years
  1. 2014 (10)
Publications
  1. ACS Chemical Biology (1)
  2. Cancer Discovery (1)
  3. Clinical Cancer Research (1)
  4. Genomics Data (1)
  5. Journal of Molecular Diagnostics (1)
  6. Laboratory Investigation (1)

More Publications

Publishers
  1. Nature Publishing Group (3)
  2. American Association for Cancer Research (2)
  3. American Association for the Advancement of Science (1)
  4. American Chemical Society (1)
  5. Elsevier Inc. (1)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genome-wide mapping of the distribution of CarD, RNAP σA, and RNAP β on the Mycobacterium smegmatis chromosome using chromatin immunoprecipitation sequencing
    Journal Article

    Landick, R.; Krek, A.; Glickman, M. S.; Socci, N. D.; Stallings, C. L.
    Genomics Data (2014)

    Fulltext@MSK | Save
  • Characterization of a set of tumor suppressor microRNAs in T cell acute lymphoblastic leukemia
    Journal Article

    Sanghvi, V. R.; Mavrakis, K. J.; Van Der Meulen, J.; Boice, M.; Wolfe, A. L.; Carty, M.; Mohan, P.; Rondou, P.; Socci, N. D.; Benoit, Y.; more...
    Science Signaling (2014)

    Fulltext@MSK | Save
  • Novel imidazoline antimicrobial scaffold that inhibits DNA replication with activity against mycobacteria and drug resistant gram-positive cocci
    Journal Article

    Harris, K. K.; Fay, A.; Yan, H. G.; Kunwar, P.; Socci, N. D.; Pottabathini, N.; Juventhala, R. R.; Djaballah, H.; Glickman, M. S.
    ACS Chemical Biology (2014)

    Fulltext@MSK | Save
  • The MSK clinical variants database and e-signout system
    Meeting Abstract

    Syed, A.; Zehir, A.; Shah, R.; Prasad, M.; Liu, Z.; Schultz, N.; Gao, J.; Gabow, A.; Wilson, M.; Socci, N. D.; more...
    Journal of Molecular Diagnostics (2014)

    Fulltext@MSK | Save
  • Synthetic lethality in ATM-deficient RAD50-mutant tumors underlies outlier response to cancer therapy
    Journal Article

    Al-Ahmadie, H.; Iyer, G.; Hohl, M.; Asthana, S.; Inagaki, A.; Schultz, N.; Hanrahan, A. J.; Scott, S. N.; Brannon, A. R.; McDermott, G. C.; more...
    Cancer Discovery (2014)

    Fulltext@MSK | Save
  • beta-Globin gene editing in human cells using TALENs and ssDNA oligonucleotides: Towards a gene repair approach for sickle cell anemia and beta-thalassemias
    Meeting Abstract

    Mansilla-Soto, J.; Socci, N.; Leyfman, Y.; Sadelain, M.
    Molecular Therapy (2014)

    Fulltext@MSK | Save
  • A recurrent point mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma
    Meeting Abstract

    Kohsaka, S.; Shukla, N.; Ameur, N.; Lim, D. ; Viale, A.; Socci, N.; Qin, L. X.; Sciot, R.; Bridge, J.; Singer, S.; more...
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations
    Journal Article

    Kohsaka, S.; Shukla, N.; Ameur, N.; Ito, T.; Ng, C. K. Y.; Wang, L.; Lim, D. ; Marchetti, A.; Viale, A.; Pirun, M.; more...
    Nature Genetics (2014)

    Fulltext@MSK | Save
  • Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy
    Journal Article

    Voss, M. H.; Hakimi, A. A.; Pham, C. G.; Brannon, A. R.; Chen, Y. B.; Cunha, L. F.; Akin, O.; Liu, H.; Takeda, S.; Scott, S. N.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • A recurrent point mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma
    Meeting Abstract

    Kohsaka, S.; Shukla, N.; Ameur, N.; Lim, D. ; Viale, A.; Socci, N.; Qin, L. X.; Sciot, R.; Bridge, J.; Singer, S.; more...
    Laboratory Investigation (2014)

    Fulltext@MSK | Save